Advanced Search
REVIEW ARTICLE
Korean J Pediatr 2011 April;54(4) :141-145.
doi:https://doi.org/10.3345/kjp.2011.54.4.141
Recommendation for the use of newly introduced Tdap vaccine in Korea
Kyong Min Choi (Choi KM), Kyung Hyo Kim (Kim KH), Yae-Jean Kim (Kim YJ), Jong-Hyun Kim (Kim JH), Su Eun Park (Park SE), Hoan Jong Lee (Lee HJ), Byung Wook Eun (Eun BW), Dae Sun Jo (Jo DS), Eun Hwa Choi (Choi EH), Young Jin Hong (Hong YJ)
The Committee on Infectious Diseases, the Korean
Corresponding Author: Kyong Min Choi ,Tel: 82.31-810-5424, Fax: 82.31-969-0500, Email: ckm2001@hanmail.net
Copyright © 2011 by The Korean Pediatric Society
ABSTRACT
Pertussis is an acute respiratory infection characterized by paroxysmal cough and inspiratory whoop for over 2 weeks. The incidence of pertussis has decreased markedly after the introduction of DTwP/DTaP vaccine, but the incidence of pertussis has increased steadily among young infant and among adolescents and adults in many countries. Td vaccine was used in this age group but the increase in pertussis has lead to the development of a Tdap vaccine. The Tdap vaccine is a Td vaccine with a pertussis vaccine added and is thought to decrease the incidence and transmission of pertussis in the respective age group. In Korea, two products are approved by the KOREA FOOD & DRUG ADMINISTRATION, which are ADACELTM (Sanofi-Pasteur, Totonto, Ontario, Canada) and BOOSTRIXⓇ (GlaxoSmithKline Biologicals, Rixensart, Belgium) for those aged between 11-64. This report summarizes the recommendations approved by the Committee on Infectious Diseases, the Korean Pediatric Society.
Keywords: Pertussis | Tdap vaccine
TOOLS
PDF Links  PDF Links
Full text via DOI  Full text via DOI
  via Pubmed
Full text via PMC  Full text via PMC
via Pubreader  via PubReader
Download Citation  Download Citation
Supplementary Material  Supplementary Material
  E-Mail
Share:      
METRICS
1,170
View
13
Download
Regionalization of neonatal intensive care in Korea  2011 December;54(12)
Recommendation for use of the newly introduced pneumococcal protein conjugate vaccines in Korea  2011 April;54(4)
Register for e-submission
Register here to access the e-submission system of Korean J Pediatr for authors and reviewers.
Manuscript Submission
To submit a manuscript, please visit the Korean J Pediatr e-submission management system at http://submit.kjp.or.kr, read the Instructions for Authors, and log into the Korean J Pediatr e-submission system. For assistance with manuscript submission, please contact: kjpped@gmail.com.
Free archive
Anyone may access any past or current articles without logging in.
Korean Pediatric Society Office
#1606, Seocho World Officetel, 19 Seoun-ro, Seocho-gu, Seoul 137-070, Korea
TEL : +82-2-3473-7305    FAX : +82-2-3473-7307   E-mail: kjpped@gmail.com
BrowseCurrent IssueFor Authors and ReviewersAbout
Copyright© The Korean Pediatric Society. All right reserved.